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RETROSPECTIVE ANALYSIS OF ETHICS CONSULTATIONS                                       
AT THE BOSTON MEDICAL CENTER 
TATSUHIKO NAITO 
ABSTRACT 
Objective: The vast majority of physicians frequently faces ethical dilemmas and feels 
overwhelmed as a result. Those at Boston Medical Center are no exception. Various studies show 
more adept handling of ethical issues can improve the quality of care and patient safety by 
reducing moral distress of physicians and fostering better patient-physician relationship. The 
method of Preventive Ethics, which actively identifies recurrent themes and underlying 
systematic issues among ethics consultations, is more effective than the traditional, case-by-case 
approach in reducing the number of ethical conflicts. The purpose of this study is to identify 
common themes prompting ethics consultations and any hotspots among recurrent ethical 
dilemmas at Boston Medical Center by using the Armstrong Clinical Ethics Coding 
System.  
Methods: A total of 32 ethics consultations handled by the BMC Ethics Committee 
between October 2010 and April 2013 were reviewed. Each consultation was coded using 
the Armstrong Clinical Ethics Coding System. The data was analyzed to identify the 
types of ethical dilemma that are most prevalent at BMC. The consultations involving the 
most frequently occurring issues were evaluated further to expose common themes 
among these cases and potential underlying systematic failures.  
Result: “Clinical Candidacy or Risk / Benefit Analysis” (6.25%), “Concern About 
Decision Maker Choices” (14.6%) and “Futility / Inappropriate or Nonbeneficial 
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Treatment” (13.5%) were the most prevalent types of ethical issues at BMC. Not only are 
these three frequently occurring, they also have a very high tendency to occur 
simultaneously. Further analysis of consultations involving these three issues revealed 
that at BMC, there are frequent instances of conflict, in which family members serving as 
healthcare proxies disagreed with physicians in deciding the best interest of patients with 
severe ailments, ultimately precipitating ethics consultations.  
Discussion: Comparison with similar retrospective studies previously carried out at other 
institutions suggests that consultation involving the issue of futility may be more frequently 
occurring at BMC, which might be coming from unique systematic problems. Several 
interventions such as improved policies or educational training in physician-family 
communication should be considered.   
Conclusion: According to the principles of Preventive Ethics, the issue of physician-healthcare 
proxy conflict regarding patient futility should be issue to be addressed at BMC. The Armstrong 
Clinical Ethics Coding System can serve as a much needed standard documentation format for 
ethics consultations, which would open up the possibility of more detailed future studies.   
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INTRODUCTION 
 
 Hospital ethical dilemmas are often a culmination of a number of unresolved 
issues that may relate, but are not limited to, patient or surrogate satisfaction with 
management of care; provider satisfaction with appropriate approach and level of care. 
Biotechnological advances in healthcare, a broader informed public and increasing 
economic constraints by healthcare providers may lead to increases in healthcare related 
ethical dilemmas. A means of accessing and employing empiric knowledge gained from 
such ethical dilemmas, which generally reflect the uniqueness of each hospital system, is 
critical to improving patient and provider experience as well as reducing healthcare costs.  
 Not only does more adept handling of ethical issues have intrinsic moral value, it 
can also improve quality of care and patient safety by reducing moral distress of 
physicians and fostering better patient-physician trust. This has become especially 
challenging in today’s age where patients’ trust in doctors has diminished.  
 This project sought to employ a validated ethics consultation coding system (the 
Armstrong Clinical Ethics Coding System) and to identify hotspots of ethical dilemmas at 
Boston Medical Center (BMC). This study retrospectively reviews all ethics 
consultations filed at BMC from October 2010 to April 2013, examines and identifies 
common themes arising among these consultants, and compares results to similar 
retrospective studies from other hospitals. By identifying these hotspots, BMC may be 
able to prevent recurrence of similar types of ethical issues, based on the concept of 
preventive ethics. 
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SPECIFIC AIMS 
Aim 1. Code and create a database of BMC ethics consultations for the period of October 
2010 to April 2013 using the Armstrong Clinical Ethics Coding System 
Aim 2. Identify common themes prompting ethics consultations and any hotspots among 
recurrent ethical dilemmas at BMC   
Aim 3. Compare the result with those from similar previous studies to identify clinically 
significant differences. 
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BACKGROUND AND SIGNIFICANCE 
 
Physicians and ethical dilemmas 
 With daily discoveries of new knowledge and technologies, quality in health care 
has evolved dramatically over the past several decades. Physicians now can prolong life 
of patients in ways that were not possible as recently as ten years ago. Innovative drugs 
that can treat formerly “untreatable” disease have become available. Despite such 
medical advancements the value of these interventions may at times be called into 
question when the gained survival time is spent hospitalized or living in a state of 
otherwise unacceptable to the patient.  
 In addition, dynamics around physicians – laws, relationships with 
pharmaceutical companies / grant providers, hospital policies –, have vastly changed and 
became increasingly complex. These changes substantially increased the chances that 
physicians encounter questions that cannot be answered by clinical expertise alone but 
rather involve consideration of what is morally right or wrong to do. These ethical 
dilemmas are not ephemeral but rather something that can haunt physicians for years (Lo, 
2012, p.11).  
 Physicians and other health care professionals often feel overwhelmed by the 
need to balance the rights, demands and needs of all the involved stake holders including 
patients, families, insurance companies and other healthcare providers (Ieong, Armstrong, 
Kolton, Parker, & Wohlgemuth, 2013). In the first national survey about the frequency of 
ethical dilemmas encountered by physicians, nearly 90% of physicians had recently 
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encountered an ethical dilemma (DuVal, Clarridge, Gensler, & Danis, 2004).  In a survey 
conducted in 2011 by the BMC Ethics Committee, 946 staff members were asked, “How 
often do ethical issues arise in your practice?”, 62% of the respondents answered “often / 
sometimes” to the question, indicating healthcare providers encounter moral dilemmas 
much more frequently than people might imagine. Despite the frequency of ethical 
dilemmas, doctors are generally reluctant to request formal ethics consultation by their 
hospital’s Ethics Committee. Some deem ethics consultations as an indication of an error 
or the lack of ability that they perceive may lead to compromising patient trusts and 
confidence of their patients (Orlowski, 2006). In the aforementioned survey at BMC, 
while 82% of respondents knew about the Ethics Committee, only 20% of them had ever 
requested a consult. According to a qualitative research study done by Hurst and 
colleagues, in the U.S., when physicians face ethical difficulties, they tend to seek 
assistance, avoid conflict, and try to protect the integrity of their conscience and 
reputation (Hurst 2005). While this may seem to contradict the BMC survey results, the 
authors argue that their findings actually explain why many doctors are reluctant to ask 
for an ethics consultation even when they face a dilemma. They hypothesize that 
physicians often deem ethics consultants as “outsiders.” Further, seeking help can lead to 
conflicts by involving more people into the equation and may undermine their integrity or 
reputation by tacitly admitting they cannot solve the problem themselves. Even when 
physicians tend to seek assistance, they may not deem ethics consultant as capable of 
providing effective help. The authors conclude that ethics consultation may be perceived 
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not as a primary source of help but more as a last resort when physicians encounter 
ethical dilemma (Hurst 2005).  
 A contributing factor to increasingly frequent ethical dilemmas may be the 
erosion of the patient-physician relationship in recent years. Many patients complain 
doctors do not spend enough time with them. In a national survey conducted by the 
federal government in 2008, many hospital patients expressed dissatisfaction with their 
care (Pear 2008). Growing number of reports indicate that patients do not trust doctors to 
the same extent as in the past. According to data from a study conducted by Johns 
Hopkins University, roughly one in four patients feel “their physicians sometimes expose 
them to unnecessary risk” (Parker-Pope 2008). Many factors contributed to distrust. A lot 
has to do with the media and the way in which even minor perceived infractions by 
physicians are considered highly newsworthy, are often presented in an inflammatory, 
exaggerated fashion, and spread instantly via the internet.  
 
 
Adverse consequences of unresolved moral dilemmas and deteriorating physician – 
patient relationship  
 Due to the high frequency of ethical dilemmas and their inability to use ethics 
consults effectively, physicians can face various adverse consequences, including moral 
distress and burnout, if they do not handle these issues adeptly.   
 Physicians feel moral distress when they know what is ethically right but cannot 
act accordingly due to constraints or obstacles. A study done by Houston and her 
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colleagues showed the issue of moral distress is prevalent throughout multiple healthcare 
disciplines including physicians and nurses. Physicians feel the greatest moral distress 
when there is a rift between the wishes of a patient’s family (when acting in the role of 
surrogate decision-makers) and what the physician himself or herself thinks should be 
done (Houston et al., 2013).  Moral distress can itself be a problem, but it can also start 
the chain of negative effects. Professional burnout is “a syndrome characterized by a loss 
of enthusiasm for work…feeling of cynicism…and a low sense of personal 
accomplishment” (Shanafelt et al., 2012). One study showed physicians experience more 
burnout than other U.S. workers. In this particular study, which consisted of almost 7000 
physicians, almost half have experienced symptoms of burnout (Shanafelt et al., 2012). 
Prior to this study, it was well known that medical students and doctors in training are 
susceptible to burnout. What is notable about this study is that even fully trained and 
experienced doctors are susceptible to the syndrome as well. Although Shanafelt never 
explicitly identified moral distress as a contributing factor to burnout there are many 
potential contributing factors, one of which may be moral distress. The problem of the 
professional can influence quality of care; physicians suffering from burnout are more 
susceptible to errors. A study conducted by Dr. West and his team showed higher levels 
of fatigue and distress leads to higher frequency of self- perceived errors among doctors 
(West, Tan, Habermann, Sloan, & Shanafelt, 2009).  
 Not only does erosion of the patient-physician relationship contribute to ethical 
conflicts, but physician-patient relationship is also paramount for effective treatment. It 
has been hypothesized that greater patient trust leads to more efficient care in several 
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ways such as better treatment adherence (Thom, Hall, & Pawlson, 2004). At worst a 
strained physician-patient relationship can result in a lawsuit which may come with 
significant financial cost to the medical center. Roughly 55 million or 2.4 % of national 
health spending was the estimated total cost of malpractice in 2008 (Reinhardt 2008).  
 In sum, give the impact the moral climate may have on providers, their 
relationship with the patient or family, and optimum use of clinical resources it would be 
expected that an environment fostering adept handling of ethical dilemmas would lead to 
better quality of care and patient safety.  
 
Ethical Consultation and its efficacy 
 Medical institutions can promote such an environment by employing out ethics 
consultations effectively. Health care ethics consultation (HCEC) is defined as a “set of 
services provided by an individual or group in response to questions from patients, 
families, surrogates, health care providers, or other involved parties who seek to resolve 
uncertainty or conduct regarding value-laden concerns that emerge in health care. The 
general goal of ethics consultation is to improve the quality of health care through the 
identification, analysis, and resolution of ethical questions or concerns” (Tarzian & 
ASBH Core Competencies Update Task, 2013).  A national survey done by Fox and her 
colleagues revealed 95% of all general hospitals in the U.S. either had some form of 
ethics consultations services or were in the process of creating one.  For those with more 
than 400 beds, the prevalence reached 100% (Fox, Myers, & Pearlman, 2007). The same 
study also revealed that “within more than 6,000 general hospitals in this country, 
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approximately 29,000 individuals devote more than 314,000 hours to ethics consultations 
each year” (Fox, Myers, & Pearlman, 2007). High prevalence of ethics consultation 
services and large investment likely reflect its efficacy and importance in improving 
quality of care and the medical staff’s mental state.   
 According to the study done by Kalager, clinicians who requested HCEC deemed 
ethics consultations as useful and stated that HCEC leads to practical consequences 
(Kalager, Førde, & Pedersen, 2011) such as termination of ongoing treatment and greater 
attention paid to ethics considerations. Other studies have reported a positive impact on 
quality and resource utilization. For example, study reported that HCEC resulted in both 
shorter ICU stay and hospital stay as compared to similar patients who did not receive 
HCEC (Chen et al., 2014). Similar studies have been done and proactive ethics 
consultations also showed benefits such more documented communication or frequent 
decisions to forgo life sustaining therapy (Nilson, Acres, Tamerin, & Fins, 2008). 
  
Preventive Ethics 
 Ethics committees and their consultations in health care setting have traditionally 
been more reactive, addressing ethical issues after they occur, on a case-by case-basis. 
Simply responding to individual cases as they occur, however, may not be quite enough. 
It has become increasingly evident that certain ethics conflicts like those involving end-
of-life issues are recurring organizational phenomena (Nelson, Gardent, Shulman, & 
Splaine, 2010). Thus the traditional case-by-case approach is now being criticized for not 
dealing with the underlying causes of these issues, which often lead to recurrence of 
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similar types of ethical dilemmas. Reappearance of similar problems eventually leads to 
avoidable moral distress and waste of resources. Nelson et al argue that while the 
traditional approach is not without benefit, “the process can be stressful and time-
consuming for both the involved staff and the ethics committee or consultation service 
members” (Nelson, Gardent, Shulman, & Splaine, 2010). As mentioned earlier, such 
negative impact can have detrimental implications including decreased quality of care 
and loss of staff productivity.  
 In response to these shortcomings of the traditional approach, a newer approach 
called preventive ethics has been developed since the 1990s. Preventive ethics is defined 
as “activities performed by an individual or group on behalf of a health care organization 
to identify, prioritize and address systemic ethical issues” (Foglia, Fox, Chanko, & 
Bottrell, 2012). This more proactive approach is intended to identify the root cause of 
ethical concerns and ultimately to prevent recurrence of similar types of ethical issues. 
While this approach has yet to become the norm for most ethical committees, it has 
distinct advantages, allowing organizations to improve their ethics practices and avoid the 
downfalls of the traditional case-by-case approach listed above. The concept of 
preventive ethics, with the attendant goal of identifying hotspots of recurrent ethical 
dilemmas at the BMC, forms the basis for this project.  
 
Ethics Committee at BMC 
 Boston Medical Center (BMC), Boston, Massachusetts, USA is a private, not-for-
profit, 496-bed hospital with more than 26,000 admissions and 850,000 visits in 2012 and 
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nearly 4,500 full-time equivalent employees including more than 1,200 physicians 
(Boston Medical Center, 2013). The Ethics Committee at BMC currently consists of 24 
members: physicians and nurses from various different specialties and representatives 
from social work, legal services, pastoral care, nursing, case management, interpreter 
services and patient advocacy. Inclusion of individuals from various backgrounds is a 
common way to compose an ethics committee and is employed by institutions nationwide 
(Fox, Myers, & Pearlman, 2007). The BMC Ethics Committee Charter includes the 
following goals (Boston Medical Center, 2007): 
• To maintain an easily accessible consultation service to assist in the assessment 
and revolution of ethical dilemmas. The consultation service shall be comprised 
of a team of individuals with interdisciplinary expertise.  
• To develop educational programs and help to foster a culture within the BMC 
community that continually increases recognition of ethical dilemmas and 
develops improving strategies to avoid, modify, and resolve frequently occurring 
ethical dilemmas.  
• To review, revise, propose, and develop policies related to ethical issues, and, as 
needed, make recommendation to the Chief Executive Office of the Boston 
Medical Center. 
• To discuss monthly those cases that have prompted request for consultation and 
create a database that can serve as an educational resource.  
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BMC Ethics Committee employs the traditional approach to HCEC of a small 
multidisciplinary consult team made up of a healthcare ethicist plus members from larger 
committee who are experienced in ethics consultation. Consults are performed with the 
requesting provider teams. Recommendations and documentation of the consult are 
entered into the patient’s chart. A more extensive form of the consult is detailed and 
entered into the Ethics Committee’s consult database. Nearly all of the Ethics Committee 
members do not have significant time in their jobs during which they are dedicated 
specifically to the ethics consultations, and thus the consult coordinator frequently needs 
to spend substantial time in recruiting and establishing a consultation team. Consequently, 
the number of consultations that can be feasibly conducted is limited, and, in fact, the 
service historically convenes for approximately one consult per month, on a par with 
other hospitals with 400-496 beds based on the research done by Fox and her colleagues 
(Fox, Myers, & Pearlman, 2007). However, both the aforementioned study by Duval 
(DuVal, Clarridge, Gensler, & Danis, 2004), as well as the survey conducted by BMC 
Ethics committee suggest it is likely that the number of ethics consults is under-
representing the actual incidence of ethical dilemmas at the BMC. Based on the national 
survey conducted by Fox, only 41% of individuals performing ethics consultations have 
had formal supervised training in ethics consultation (Fox, Myers, & Pearlman, 2007). 
The general lack of formal training in clinical ethics among staff members in ethics 
committee can also be applied to the BMC Ethics Committee, where generally just two 
members of the consult service meet the recommended American Society of Bioethics 
and Humanities (ASBH) skill and knowledge competencies (Ieong, Armstrong, Kolton, 
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Parker, & Wohlgemuth, 2013). In sum, HCEC performed at BMC appear to be on par 
with other comparable hospitals in the country. 
 
Documentation and Evaluation of HCECs 
 In the late 2000s, many bioethicists decried the lack of formal practice standards 
for HCECs (Fox, Myers, & Pearlman, 2007; Dubler, Webber, & Swiderski, 2009). 
Expanding on an initiative begun years earlier, the ASBH published the second edition of 
Core Competencies for Healthcare Ethics Consultation (CC HEEC), which codified 
standards for a successful and efficient HCEC service. A key component of these 
standards is thorough documentation of all consultations.  
 Clear, organized and consistent documentation of HCEC records is crucial as it 
serves multiple purposes. First, it facilitates evaluation of ethics consultations and the 
activities of the ethics committee. This will ultimately facilitate quality improvement of 
the ethics consultation service by making it easier for evaluators to identify trends in 
consultations and potential area of systematic improvement. In fact, evaluation / quality 
review / improvement of the HCEC services is another proposed standard of HCEC 
serviced identified by the CC HEEC. Dubler argues, “[q]uality improvement is 
mandatory in all subspecialties of health care. As HCEC moves into the mainstream, it 
must be judged by mainstream standards. Clinical ethics committees and clinical ethics 
consultants must be subjected to the same level of transparency, account-ability, scrutiny, 
and oversight as other members of the staff who see patients, and, like other members of 
the staff, they must write notes in the chart” (Dubler, Webber, & Swiderski, 2009). 
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Second, related to the first purpose, properly documented ethical consultations can be 
utilized as a valuable educational material. Previous studies indicate that both general 
staff of an institution (Chen et al., 2014) and members of an ethics committee (Fox, 
Myers, & Pearlman, 2007) can benefit from more education on health care ethics. Third, 
appropriate documentation can facilitate research on clinical ethics consultations. 
Bramsteadt laments “[m]any facilities have performed hundreds of ethics consultations 
that contain valuable information that could generate research protocols, yet accessing 
this information can be difficult because it is not formally catalogued” (Bramstedt, 
Jonsen, Andereck, McGaughey, & Neidich, 2009). Last and most importantly, consistent 
standardized documentation facilitates discussions and exchange of understanding 
between different institutions by providing a common ground and structure. A lesson can 
be learned from the first few meetings of European Clinical Ethics Network (ECEN) 
meeting where participants had difficulty in sharing their experience and knowledge 
because they did not share the same documentation format or more specifically, technical 
languages (Pedersen et al., 2010). It is possible that such a standardized structure may 
restrain ways of presentation or discussion to some extent, but it is safe to assume 
potential benefits will far outweigh potential drawbacks.  
 Yet, despite the potential benefits, formal standards of documenting ethics 
consultation are yet to be established. Bramsteadt writes, “[a]n exhaustive literature 
review reveals no consistent description of what is recorded and how it is recorded. What 
few methods are published, in our view, could be improved upon. Further, no regulatory 
or professional body (for example, the American Society for Bioethics and Humanities) 
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has set standards for documentation of ethics consultation” (Bramstedt, Jonsen, Andereck, 
McGaughey, & Neidich, 2009). Inconsistencies in documentation can also be seen in past 
retrospective review of ethics consultations. 
 For example, a study done by Moeller had nine categories to classify central 
issues of ethical consultations (Moeller et al., 2012).   
• Family opposed to withdrawing life sustaining treatment (LST) 
• Physician does not wish to provide LST 
• Patient competence or capacity in question 
• Futility 
• Physician opposed to withdrawing LST 
• Other 
• DNR 
• Patient noncompliance with medical regimen 
• Patient wishes are unknown 
 
Retrospective studies done by Swetz (Swetz et al., 2007) and (Romano, Wahlander, Lang, 
Li, & Prager, 2009) were a little more expansive with 15 categories:  
• Withdrawing or withholding treatment 
• Appropriateness or treatment, goal of care, futility 
• Resuscitation issues 
• Legal-ethics interface 
• Competency, decisional capacity 
• Psychiatric issues 
• Family conflict 
• Staff or professional conflict 
• Discharge disposition 
• Allocation of resources  
• Spirituality, cultural issues 
• Confidentiality 
• Advance directives 
• Reproductive issues 
• Other 
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Analyses using these categorization systems clearly demonstrated that one ethics 
consultation can involve multiple issues. Yet, these early coding systems did not establish 
the recommended number of categories to apply to a single consultation. In other words, 
one consultation might be labeled with a single category while others might be labeled 
with more than one. This was addressed in Nilson’s study (Nilson, Acres, Tamerin, & 
Fins, 2008), which proposed listing of one primary issue and one secondary issue out of 
22 categories:  
• Advance Directive 
• Brain Death 
• Capacity / Informed Consent  
• Confidentiality  
• Discharge / Placement 
• DNR 
• Futility 
• Isolated Incapacitated Patient 
• Maternal / Fetal Conflict 
• Medical Error 
• Pain Management 
• Refusal of Recommended Treatment 
• Research Ethics 
• Resource Allocation 
• Surrogate Decision Making 
• Transplant Issues 
• Truth Telling 
• Withdrawal of Ventilator 
• Withdrawal of other life sustaining therapy 
• Withdrawal or Withholding Artificial N&H 
• Withholding of other life sustaining therapy 
• Other 
 
Such inconsistency in categorizing central issues of an ethics consultation or any other 
areas of documentation will make discussions and comparisons between two parties (e.g., 
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individuals, teams, institutions, countries) using different format extremely difficult since 
they do not share the same technical language. It can also impede efficient evaluation and 
subsequent research. In addition, prior studies never adequately explained the definition 
of each category while some of them used ethics specific technical language. 
Compounding the aforementioned general lack of formal training in ethics among the 
Committee members, this lack of standardization in documentation can contribute to 
miscommunication. Therefore, a standardized documentation or coding system to 
categorize and organize central issues in ethics consultations was much needed. The 
Armstrong Clinical Ethics Coding System (ACECS) was specifically designed for that 
purpose.  
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METHODS 
Study Design  
 All cases from the BMC Ethics Committee Consult database from October 2010 
to April 2013 (total 32 consultations) were included in the analysis. The Ethics 
Committee Consult service documents each consult in an established template in 
narrative form. Although there are no proscriptive directions, the components generally 
found in each consult include: patient history; description of clinical status; description of 
ethical dilemma as described by requesting parties and other consult participants; major 
issues as observed by the consult team; recommendations made; and in some instances, 
outcomes.  
 The completed consultation document for each consultation was coded using the 
Armstrong Clinical Ethics Coding System (ACECS) based on its central ethical conflict. 
After the coding was complete, the data was analyzed to identify the types of ethical 
dilemma that are most prevalent at the BMC.  
 
Armstrong Clinical Ethics Coding System 
 The Armstrong Clinical Ethics Coding System (ACECS) was developed by Dr. 
Kelly Armstrong at Southern Illinois University School of Medicine, a practicing clinical 
ethicist who has conducted over 1800 ethics consultations over the last 10 years. ACECS 
has been successfully adopted at various healthcare institutions including within the 
Boston hospital community at Boston Children’s Hospital.  
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 The ACECS uses 138 detailed descriptors of commonly experienced ethical 
issues in healthcare that are sorted into nice categories: 1) Treatment Decision-Making 2) 
Substitute Decision-Making 3) End of Life 4) Professionalism 5) Reproduction 6) Death 
and Post-Mortem 7) Resource Allocation 8) Research and 9) Organizational Ethics. Each 
subject group is then sub-divided to the more detailed descriptor classifications. For 
example, there are 9 codes under group 6 Death and Post-mortem (See Appendix 1 for 
the full list):  
01 Brain Death 
02 Autopsy 
03 Visitation of location of Body After Death 
04 Participation in Learning Exercise 
05 Anatomical Donation 
06 Release of Body/Disposition of Remains 
07 Coroner/Medical Examiner/Other Government Service 
08 Bereavement Counseling 
09 Memorialization (hair, footprints, photo, etc.)  
Each of the 138 codes in the coding system is assigned a number, the first numeral being 
the governing subject group category. In the above example, “Autopsy” is assigned the 
code 6.02.  Each consultation is tagged with the three different codes that best describe 
the case specific ethical dilemma. Thus there are theoretically 428,536 possible ways to 
describe a consultation.  
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 In addition, three modifiers are used to describe the dynamics and type of each 
consult: 1) Types of Ethics Intervention 2) Locus of Uncertainty or Conflict and 3) Level 
of Complexity (See Appendix 2 for the full list).  
 One of the strengths of the coding system is that it covers a broad range of issues 
that can potentially surface in daily clinical settings without resorting to lengthy 
description. Another strong point is that the system avoids highly technical ethics specific 
language, making it comprehensible not only to physicians but also to other care 
providers such as nurses. To further clarify and standardize, the coding system a user’s 
guide was developed to provide a working definition and examples for each code. For 
example, a code “Uncooperative Behavior” is defined as (Armstrong, 2013): 
Words or Actions which, through their severity or frequency, are 
disruptive enough to impair normal social interactions or the effective 
delivery of healthcare services. Generally observed as difficulty 
containing a strong emotional response (fear, anger, frustration, etc.) or 
a difficulty following the rules. This may be applied to all persons 
involved in care, including the patient, family and healthcare team. 
 
Examples: Yelling, badgering, manipulating, bullying, refusal to 
participate in discussions or meetings, impulsive behaviors, inability or 
refusal to follow directions.  
 
Commonly combined with: Decisional Capacity, Mental Illness, 
Substance Use, Family Issues, Concern about Decision-Maker Choices, 
Professionalism, Inappropriate Treatment, Maternal-Fetal Conflict, 
Abuse Neglect or Mandatory Reporting  
 
Through support material like this, webinars and workshops, Dr. Armstrong has 
successfully trained other institutions to use the coding system. In sum, the above 
elements make the coding system very adoptable. This is especially important 
20 
 
considering staff from various backgrounds or fields comprises HCEC’s and, as has been 
reported, many have not had a formal education in clinical ethics. 
 Since the ACECS can be fairly easily adopted by most Ethics Committee 
members it may provide a core language that is standardized and connected to the 
healthcare ethics literature. Its consistency and conciseness helps the members to avoid 
miscommunications, discuss active issues efficiently and facilitate recording that may be 
used for evaluation or research later. These benefits would be expected to lead to improve 
quality of HCEC and ultimately result in better quality of patient care and safety.  
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RESULTS 
General Classification   
 32 consultations were conducted over a period of 31 months. A single case was 
tagged with three different codes which each describes a very specific type of ethical 
dilemma or conflict (appendix 1). In other words, 96 codes were applied in this analysis. 
Some codes were used more often than others which reflect the types of ethical issues 
occurring more frequently than other types.  
 As described earlier, the specific ethical issues or their corresponding codes that 
share the common theme are bundled together under the same subject group and there are 
nine of them (Figure 1). Of the total 96 codes used, 29 (30.2%) of them were the ones 
that falls under the subject group “Treatment Decision Making. 29 (30.2%) of them are 
from “Substitute Decision Making” and 26 (27.1%) belonged to “End of Life.” Those 
three subject groups were the ones that are most prevalent throughout the consultations 
filed to the BMC during the period. There are modest frequency of issues under 
“Professionalism” (7 out of 96; 7.29%) and “Reproduction” (4 out of 96; 4.17%) and 
only a single occurrence of “Organizational Policy” (1 out of 96; 1.04%). On the other 
hand, there was no consultation that were linked to issues involving “Death and Post-
Mortem,” “Resource Allocation” and “Research.”  
 The reason why the number of codes instead of the number of cases was used to 
measure the frequency of certain ethical issues is that some cases were tagged with more 
than one code from the same subject group. A single case can be tagged with up to three 
codes. For example, it is possible to label a consultation with codes “Resuscitation for 
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Full Arrest (Code # 3.01)”, “Futility / Inappropriate or Nonbeneficial Treatment (Code 
#3.10)” and “Concern About Decision-Maker Choices (Code #2.04).” In this case, the 
first two cases belong to the same subject group “End of Life.”   16 out of 32 cases 
(50.0%) were tagged with 2 or 3 codes from the same subject group. This creates a 
significant overlap when the number of cases was used to measure the frequency of 
issues and was thus avoided.   
 
Figure 1: Frequency of ethical issues for each Subject Groups. The number of codes 
(total = 96) used from each subject group was employed as a parameter to measure the 
frequency of ethical issues. The distribution reveals ethical issues that fall under 
“Treatment Decision Making,” and/or “Substitute Decision Making” and/or “End of Life” 
were most prevalent. 
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Figure 2: Frequency of consultations that were tagged with more than one code 
from the same subject group. The number of cases (total = 32) was used as a parameter 
to measure the frequency. Exactly a half of total cases were labeled with 2 or 3 codes 
from the same subject group.   
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Specific Issues under Treatment Decision Making  
 
Figure 3: Frequency of specific types of ethical issues under Treatment Decision 
Making. The number of times a particular code was used was employed as a parameter 
to measure the frequency of ethical issues. The codes from this particular subject group 
were used total 29 times. Out of 26 different specific codes, only 13 of them were 
actually used. Code #1.05, which denotes “Clinical Candidacy or Risk / Benefit Analysis” 
was used most frequently. “Goals of Care,” “Mental Health and / or Treatment,” 
“Vulnerable Person,” and “Family Issue” also had relatively higher frequency.    
 
 Of the 22 cases that had codes belonging to the subject group Treatment Decision 
Making, 16 of them had only one code from the subject group. Six of them had two codes 
while one had its all three codes from the subject group. This means a total of 29 codes 
(out of 96; 30.2%) that belong to the subject group were assigned to the consultations. 
Within the subject group, there are 26 specific codes or subcategories that each pertains 
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to more specific ethical issues of the topic (Appendix 1). Each specific code can be used 
only once per case. For example, you cannot use the code “Mental Health and /or 
Treatment (Code # 1.07)” twice on one case; thus there’s no chance of overlap. In other 
words, if the code was used three times, there were three different cases that were labeled 
with that code. The frequency of issues that belong to each subcategory was measured 
(Figure 3). Of the 26 specific types of issues within the subject group, only 13 of were 
actually observed (and 7 of them were used only once). The most prevalent issue under 
this particular category was ones related to “clinical candidacy or risk / benefit analysis 
(Code # 1.05).” Of the total 96 codes from the entire sample (29 codes from this subject 
group), six of them were this particular code. (Since there’s no overlap, this also means 
that, of the total 32 cases, six of them were tagged with this code). This marks the 
frequency of 6.25% (6 out of 96).  Issues about “Mental Health and /or Treatment,” 
“Vulnerable Person,” (both 4.17%; 4 out of 96) “Goals of Care,” and “Family Issues” 
(both 3.13%; 3 out of 96) were also relatively prevalent as well.  
 
Specific Issues under Substitute Decision Making  
 25 consultations had codes from the subject group “Substituted Decision Making.” 
21 of them had only one code from the subject group while four had two codes. 
Therefore, total 29 codes (out of 96; 30.2%) that belong to the subject group were 
assigned among 32 consultations. Within this particular subject group, there are 16 
specific codes or subcategories (Appendix 1). Of the 16 specific types of issues within 
the family, 10 of were actually observed (and 5 of them were used only once). The issue 
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of “Concern About Decision-Maker Choices (Code #2.04)” was dominantly prevalent 
within this subject group (Figure 4). Of the total 96 codes from the entire sample (29 
codes from this subject group), 14 of them were this particular code. Not only does this 
make the frequency 14.6% (14 out of 96), it almost makes up the half of all codes from 
this particular subject group. Issues related to “Advanced Directive – Patient Wishes Not 
Followed (Code #2.14)” had moderate frequency of 4.17% (4 out of 96).  
 
 
 
Figure 4: Frequency of specific types of ethical issues under Substitute Decision 
Making. The number of times a particular code was used was employed as a parameter 
to measure the frequency of ethical issues. The codes from this particular subject group 
were used total 29 times. Out of 16 different specific codes, 10 of them were actually 
used. Code #2.04, which denotes “Concern About Decision Maker Choices” was used 
predominantly. Use of Code #2.14, “Advanced Directive Patient Wished not Followed,” 
had relatively higher frequency.   
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Specific Issues under End of Life 
 There were 21 cases that were labeled with at least one code from this particular 
subject group “End of Life.” 16 of them just had one code while 5 of them had two. Thus, 
a total of 26 codes (out of 96, 27.1%) were used among 32 cases.  Within this particular 
subject group, while there are 11 subcategories (Appendix 1), only four of them were 
actually used. Among the four, the issue of “Futility / Inappropriate or Nonbeneficial 
Treatment (Code # 3.10)” was most prevalent by a large margin (13.5%; 13 out of 96). It 
makes exactly the half of all codes from this particular subject group. While not as 
explicit, the remaining three still had moderately high frequency as well: “Resuscitation 
of Full Arrest (4.17%; 4 out of 96),”  “Withhold / Withdraw Life-Sustaining Treatment 
(6.25%; 6 out of 96)” and “Palliative Care / Symptom Management (3.13%; 3 out of 96).” 
 
Figure 5: Frequency of specific types of ethical issues under End-Of-Life. The 
number of times a particular code was used was employed as a parameter to measure the 
frequency of ethical issues. The codes from this particular subject group were used a total 
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of 26 times. Out of 11 different specific codes, only 4 of them were actually observed. 
Code #3.10 for “Futility / Inappropriate or Nonbeneficial Treatment” was used 
predominantly.  
 
 
Specific Issues under Professionalism  
 The subject group “Professionalism” had seven codes (out of 96; 7.29`) from six 
cases with in the sample (fives cases with one code while one case with two). Within this 
particular subject group, there are 19 subcategories (Appendix 1). Yet, only five of them 
were actually observed. Among the five, the subcategory “Moral Distress (Code #4.05)” 
was most frequently used (3 out of 96; 3.12%). The other four were all used only once.  
 
Figure 6: Frequency of specific types of ethical issues under Professionalism: The 
number of times a particular code was used was employed as a parameter to measure the 
frequency of ethical issues. The codes from this particular subject group were used a total 
of seven times. Out of 19 different specific codes, only 4 of them were actually observed. 
Code #4.05 for “Moral Distress” was used most frequently. 
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Issues that coincide with Clinical Candidacy or Risk / Benefit Analysis 
 As stated above, there were six cases that involved the issues that can be 
classified as “Clinical Candidacy or Risk / Benefit Analysis.” (i.e.: the code for “Clinical 
Candidacy or Risk / Benefit Analysis,” Code #1.05, was used six times while cataloguing 
the 32 consultations). This was the most prevalent type of ethical issues under the 
Treatment Decision Making subject group. Because each consultation is labeled with 
three different codes, among these six cases that share Code #1.05, there are a total of 12 
additional codes. In fact, there were eight different subcategories that occurred 
simultaneously with Code #1.05. Examining the distribution of these codes reveals the 
trend of ethical issue subcategories that coincide with “Clinical Candidacy or Risk / 
Benefit Analysis” (Figure 7). Among the 12 codes from the six cases, three of them were 
Code #2.04 (Concern About Decision-Maker Choices) and another three were Code 
#3.10 (Futility / Inappropriate or Nonbeneficial Treatment). This means there were three 
consultations that were tagged with both Code #1.05 and Code #2.04. Similarly, This 
means there were three consultations that were tagged with both Code #1.05 and Code 
#3.10. It is noteworthy that these two combinations are not mutually exclusive. In fact, 
there was one consultation that had all Code #1.05, #2.04 and #3.10.  
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Figure 7: Ethical Issues that co-occurred with Clinical Candidacy or Risk / Benefit 
Analysis. The number of times a particular code was used was employed as a parameter 
to measure the frequency of ethical issues matching the criterion. “Concern About 
Decision-Maker Choices” and “Futility / Inappropriate or Nonbeneficial Treatment” 
showed stronger tendency to coincide with “Clinical Candidacy or Risk / Benefit 
Analysis.” 
 
 
Issues that coincide with Concern About Decision-Maker Choices 
 Aforementioned 14 cases that demonstrated Concern About Decision-Maker 
Choices (Code #2.04) made it most predominant subcategory of ethical issues under the 
subject group “Substituted Decision Making.” Among these 14 cases, there were total 28 
additional codes that demonstrate types of issues that co-occurred with Concern About 
Decision-Maker Choices (Figure 8). 13 different types of ethical issues fit the criteria. 
Futility / Inappropriate or Nonbeneficial Treatment once again was very prevalent among 
the cases of interest (There were seven consultations that could be described as both 
“Concern About Decision-Maker Choices” and “Futility / Inappropriate or Nonbeneficial 
Treatment.” However, under this particular condition, the subcategory was single- 
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handedly dominant. There were several subcategories that had relatively higher co-
occurrence rate than other: “Clinical Candidacy or Risk Benefit Analysis”, “Resuscitation 
of Full Arrest” and “Withhold or withdraw Life Sustaining Treatment.”  
 
 
Figure 8: Ethical Issues that co-occurred with Concern About Decision-Maker 
Choices. The number of times a particular code was used was employed as a parameter 
to measure the frequency of ethical issues matching the criterion. “Futility / Inappropriate 
or Nonbeneficial Treatment” showed very strong tendency to coincide with “Concern 
About Decision Maker.” 
 
 
Issues that coincide with Futility / Inappropriate or Nonbeneficial Treatment 
 As stated in the previous section, there were 13 consultations that were tagged 
with Code #3.10 Futility / Inappropriate or Nonbeneficial Treatment, most frequently 
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occurring type under the End of Life Subject Group. Among these 13 consultations that 
share the code #3.10, there total 26 additional codes, which represent types of ethical 
issues that tend to coincide with “Futility / Inappropriate or Nonbeneficial Treatment.” 
These 26 codes come from 12 different specific types (Figure 9). Concern About 
Decision-Maker Choices showed the highest coincidence rate, which fits perfectly with 
the result stated in the section right above. “Clinical Candidacy or Risk / Benefit Analysis” 
and “Resuscitation for Full Arrest” had relatively higher rate.   
 
 
Figure 9: Ethical Issues that co-occurred with Futility / Inappropriate or 
Nonbeneficial Treatment. The number of times a particular code was used was 
employed as a parameter to measure the frequency of ethical issues matching the 
criterion. “Concern About Decision Maker” showed very strong tendency to coincide 
with “Futility / Inappropriate or Nonbeneficial Treatment.”  
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Modifiers  
 As previously stated, there are three different layers of modifiers: 1) Types of 
Ethics Intervention 2) Locus of Uncertainty or Conflict and 3) Level of Complexity 
(Appendix 2).  
 For the modifier level 1, 20 of 32 consultations were classified as “Conflict or 
Disagreement,” seven were “Values Clarification and Integration,” four were 
“Clarification / Analysis of Issues or Problem Solving” and one was “Documentation, 
Policy, Legal Issue.” 
 For the modifier level 2, in the majority of cases, uncertainty or conflict resides in 
either between Patient’s Family and Team (16 out of 32) or Patient and team (9 out of 32).  
 For the modifier level 3, all of the cases apply to either Intermediate or Advanced 
level of complexity.  
 
Examining the Three Major Hits 
  
 For the sake of simplicity, “Clinical Candidacy or Risk / Benefit Analysis”, 
“Concern About Decision Maker Choices” and “Futility / Inappropriate or Nonbeneficial 
Treatment” are now called “The Three Major Hits.” As the previous three sections 
suggested, they tend to co-occur with one another. Of the 32 consultations examined, 20 
of them were classified with at least one of the three. 12 of them had more than one of the 
three (i.e. coincidence). There was one case that had all of the three. These overlaps are 
depicted in the Figure 10.   
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Figure 10: Intersections of consultations involving the Three Major Hits. Venn 
Diagram of consultations that were classified with at least one of the Three Major Hits 
(Clinical Candidacy, Concern about Decision Maker and Futility).  
 
 One of the advantages of the ACECS is that it allows one to narrow down to the 
themes of consultations that represent recurrent ethical dilemmas. By re-evaluating 
representative cases and scrutinizing what exactly elicited these consultations, one may 
be able to expose underlying reasons and possible systematic problems. The organization 
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can then work to address these underlying issues and/or systematic problems to attempt 
to prevent future ethical dilemmas.   
 There were six consultations that involved the issue of Clinical Candidacy or Risk 
/ Benefit Analysis. The ACECS defines it as follows (Armstrong, 2013):  
1.05 Clinical Candidacy or Risk / Benefit Analysis 
The consideration of whether a medical or surgical procedure is worth 
risk to the patient as compared to anticipated benefits. Intervention that 
can provide care for a patient’s condition may provide unacceptable 
harm as well and prompt a care provider to determine that a patient is 
ineligible for clinical intervention. 
 
Example: Surgical Procedures, chemotherapy and other 
pharmacotherapy, end of life care, futility, procedures / examinations 
performed under anesthesia, organ transplantation, clinical trial 
exclusion  
 
These six consultations were identified and revisited for further evaluation. In five cases, 
patients’ clinical candidacy was questioned because proposed treatments, including 
surgeries, were aggressive and were accompanied by significant risks or side effects. The 
remaining one case involved a novel treatment (fecal transplant) that had never been 
implemented at the BMC. In all six cases, patients were inflicted with severe ailments 
including metastatic cancers, traumatic brain injury and severe Clostridium difficile 
infection. The trend is hardly surprising since non-severe ailments usually do not require 
aggressive treatments that are controversial enough to elicit the issue of Clinical 
Candidacy due to its potential risks. In addition, the definition itself explains why this 
particular type of ethical issue tends to coincide with that of Futility / Nonbeneficial 
Treatment.  
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 14 consultations involved the issue of Concern About the Decision Maker 
Choices. It is defined as follows (Armstrong, 2013):  
2.04 Concern About Decision-Maker Choices 
When a stake holder express concern that the designated decision-
maker is not, or cannot, make decision in the best interest of the patient 
or in keeping with the patient’s wishes, values or beliefs  
 
They were re-examined with one focus: who were the designated decision makers 
(proxies) in each case? In 12 cases, it was patient’s family member(s) who were in a 
position to make the decision on behalf of the patients. Even when multiple family 
members were involved in the decision making process, there was usually one single 
legal health care proxy. There was one case that had a protective service agency as a 
decision maker. The last remaining case had a court appointed guardian as a legal health 
care proxy.   
 Moreover, 13 consultations that involved the issue of Futility / Inappropriate or 
Nonbeneficial Treatment were revisited to chart what exactly was considered as futile in 
each case. The definition of Futility / Inappropriate or Nonbeneficial Treatment per the 
ACECS (Armstrong, 2013):  
3.10 Futility / Inappropriate or Nonbeneficial Treatment  
Treatment provided to a patient when there is no reasonable hope for 
cure or benefit, or whose goal is merely prolonging the dying process.  
 
Commonly combined with: Resource Allocation, Cost, Policy, Extent 
of Decision-Maker Power, Goals of Care, Family Issue, Palliative Care, 
Advocacy or Social Responsibility  
 
In 10 cases, what was considered as potentially futile was initiation or continuation of 
aggressive and curative treatments on patients whose ailments are near the end stage (In 
37 
 
these cases, they are suffering from not only originally diagnosed ailments but also 
various complications stemming from them). In two cases, initiation or continuation of 
life sustaining treatment was deemed as potentially futile. In the remaining one case, 
keeping the patient’s full code status was deemed as futile.  
 Following this, eight consultations that involved BOTH “Concern About the 
Decision Maker Choices” and “Futility / Inappropriate or Nonbeneficial Treatment” were 
re-examined to expose a potential common theme. As previously noted, these two “hits” 
showed significant overlap (Figure 8-9). In seven cases, patients’ family (who participate 
as designated decision makers) insisted on the continuation of curative or life-sustaining 
treatments while the teams (physicians) believed such was not for the best interest of the 
patients due to their poor conditions and prognosis. In the remaining one case, a family 
member (proxy) was more supportive of palliative care while the patient had expressed 
the desire to “do everything” and the team believed there was indeed some chance of 
meaningful recovery. 
 Therefore, it can be concluded, at BMC, there are frequent instances (25%; 8 out 
of 32 total cases) that a discrepancy between patients’ family (who is also partaking as 
designated proxy) and physicians’ team, in terms of what is the best interest of the patient, 
goes unresolved and  precipitates ethics consultations. Most of the times, it occurs 
because families are unable to give up on patients with a minimal chance of meaningful 
recovery. This is only bolstered by results shown by the modifiers. 62.5% (20 out of 32) 
of consultations were classified as “Conflict or Disagreement” and 50% (16 out of 32) of 
cases had uncertainty or conflict between “Patient’s Family and Team.” This tendency of 
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conflict to arise over the issue of “futility” is somewhat consistent with similar 
retrospective studies done in the past, (Moeller et al., 2012; Swetz et al., 2007; Romano, 
Wahlander, Lang, Li, & Prager, 2009; Nilson, Acres, Tamerin, & Fins, 2008) yet still 
could be linked to the systematic problem unique to the BMC.  
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DISCUSSION 
 The study demonstrated that ethical issues related to “Treatment Decision 
Making,” “Substitute Decision Making,” or “End of Life” were most prevalent and more 
likely to elicit ethics consultations at BMC (Figure 1).  
 More specifically, “Clinical Candidacy or Risk / Benefit Analysis” (belonging to 
the Treatment Decision Making Subject Group), “Concern About Decision Maker 
Choices” (belonging to the Substitute Decision Making Subject Group) and “Futility / 
Inappropriate or Nonbeneficial Treatment” (belonging to the End of Life Group) are 
recurrent themes throughout the consultations examined (Figure 3-5). Not only are these 
“Three Major Hits” prevalent, they also have a very high tendency to occur 
simultaneously at BMC (Figure 10).  
 Further evaluation of consultations involving the Three Major Hits revealed 
several interesting trends at BMC. First, the clinical candidacy of patients was questioned 
mostly because aggressive treatments with significant risks were proposed in order to 
counter ailments in dire conditions. Second, when there is a concern about decision 
maker’s choices, it is often the patient’s family member(s) who are designated to make 
decision for patient’s behalf. Third, treatments considered as futile were mostly curative 
and aggressive treatments on patients with minimal chance of meaningful recovery. 
Finally, there are frequent instances that family members partaking as proxy disagree 
with physicians in deciding the best interest of patients with severe ailments, which 
eventually lead to ethics consultations. In order to have better grasp of this trend, the 
result of this study was compared to other studies carried out in the past.  
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Comparing with the Past Studies 
 
 Similar retrospective studies have been done in the past. Comparing this study to 
them may expose issues that are unique to BMC. It must be noted, however, the 
classification system is vastly less expansive compared to the ACECS. It usually 
consisted of a mere nine to 22 specific categories contrary to the ACECS’s 138. As 
mentioned in the introduction, such discrepancy makes a perfect comparison between 
different studies almost impossible.   
 Moeller used a nine category classification system in his retrospective study 
(Moeller et al., 2012). He observed a total of 195 reasons for the 100 ethics consultations 
he analyzed.  His five most frequently reported reasons for the ethics consultations were: 
“(1) Family opposed to withdrawing life-sustaining treatment (LST), (2) Physician does 
not wish to provide LST, (3) Patient competence or capacity in question, (4) Issues of 
futility, and (5) Physician opposed to withdrawing LST. While the issue of futility was 
the fourth in the order, its raw frequency (observed in 25 cases out of 100) was not too far 
behind the top three (28, 27 and 27 out of 100, respectively).  
 Swetz retrospectively studied his 255 consultations using a classification system 
with 15 categories (Swetz et al., 2007). Just like Moller’s study, consultations were 
requested for multiple reasons. The leading reason for consultations was “Competency, 
decisional capacity,” which applied to 82% of his consultations. It was followed by: 
“Staff or Professional Conflict (76%),” “Quality of Life, end-of-care (60%),” 
“Appropriateness of treatment, goals of care, and futility (54%)” and “Withdrawing or 
withholding treatment (52%).”  
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 Romano used Swetz ‘s classification system to analyze his 168 consultations 
(Romano, Wahlander, Lang, Li, & Prager, 2009). The most common reason for ethics 
consultation request was “Withdrawing or withholding treatment (108 of 168; 64%), 
followed by Appropriateness of treatment, goals of care, and futility (14%),” 
“Competency, decisional capacity, (10%),” “Resuscitation Issues (8%)” and “Legal-
ethics interface (7%).” 
 Finally, Nilson used a 22 category classification system to study 53 consultations 
(Nilson, Acres, Tamerin, & Fins, 2008). Common ethical dilemmas encountered were 
“Withdrawal of life sustaining-care (28 out of 53),” “advance directives (15),” 
“Withholding of life sustaining therapy / DNR (8),” “Refusal of recommended treatment 
(6),” “capacity/informed consent (5)”, “surrogate decision making (5)”, “withholding of 
other life-sustaining therapies (4)”, “futility (4)”, and “issues with isolated, incapacitated 
patients (4).” 
 These past studies show the issue of futility can be one of the most common 
reasons for ethics consultations (Swetz and Moeller), although not uniformly the case 
(Romano or Nilson). In this particular study at BMC, the issue of futility was the second 
leading specific reason for consultations (involved in 13 cases out of 32; 40.6%) only 
behind the issue of Concern about Decision maker choices (14 cases of 32; 43.8%). First, 
this ranking demonstrates the issue of futility is a more significant problem than at the 
institutions in which Romano’s and Nilson’s studies took place. Second, this study shows 
higher raw frequency (40.6%) than Moeller’s (25%). Finally, Swetz’s classification 
system does not include a specific code for the issue of clinical candidacy (the third 
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leading cause at the BMC with 18.8%) like the ACECS does. Also, the issue of futility is 
bundled together as “Appropriateness or treatment, goal of care, futility.” Once again, the 
ACECS has is an individual code for the issue of goals of care (Appendix 1). Therefore, 
it can be argued that the actual number could be lower if Swetz’s samples were tagged by 
the ACECS. In sum, comparison with the past studies demonstrates the frequency of 
ethical issues involving futility leading to ethical consultations may be higher in BMC 
than the norm. There are several possible explanations for this. First, it may have to do 
with the level of care BMC is providing. Since the institution specializes in the very 
advanced level of tertiary medical care, it is safe to assume that BMC deals with patients 
in more complex and dire condition than many other institutions. This larger denominator 
may lead to more cases involving the issue of futility. Another potential explanation is 
the diversity of patients BMC is serving, especially in terms of their ethnicity. As 
explained in the next section, different cultures have different perspectives, which may 
turn into a source of miscommunication between physicians and patients’ surrogates.   
 
Potential Intervention to address the issue of futility at the BMC 
 While the issue of futility itself is universal among health institutions, its 
relatively higher frequency could be considered reflection of systematic problems unique 
to BMC. In addition, this study newly exposed intricate relationship between the issues of 
futility with other very common ethics problems such as substituted decision making (As 
past studies never analyzed the combination of reasons leading to ethics consultations or 
re-visited consultations for sake of more context). Therefore, it can be argued that this 
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particular issue or systematic flaw that’s causing it is something that needs to be 
addressed first over other types of ethical issues at BMC.  
 According to Lo (Lo, 2012, p.121), one systematic way to facilitate avoiding or 
resolving conflicts involving the issue of futility is developing written guidelines about 
futile / nonbeneficial treatments. This enables physicians to demonstrate that their 
decisions regarding futile treatments are based on well considered standards, not on 
something random.  Lo cites the Houston Policy as one of the models of institutional 
policy on futile treatment. The Houston Policy emphasizes these three points:  
“[t]he first is that rather than relying on a substantive definition of 
futility, the policy should rely on a procedural approach that recognizes 
the importance of thorough institutional review of each case. The 
second is that the policy should be based on open and fair processes 
involving patients, physicians, and institutions. The third is that the 
policy should be clearly grounded on professional integrity and 
institutional integrity as a balance to patient autonomy.” (Halevy & 
Brody, 1996) 
 
Joseph reviewed recently published studies and their empirical data regarding the role of 
hospital policy on medical futility in conflict resolutions (Joseph, 2011). He concluded 
that hospital policies on medical futility are effective in resolving conflicts and improving 
end-of-life care. Therefore, one potential intervention to be considered is to establish or 
review and improve their policy / guideline regarding the issue of futility / nonbenefiicial 
treatment at BMC.  
  Another important aspect brought up by Lo is better communication between 
physicians and surrogates. While many physicians tend to avoid unpleasant discussions 
about futile treatments with patients / surrogates and opt to make decisions unilaterally 
instead, Lo argues that it is better to have more discussions than having less. Via 
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discussion with patients or surrogates, physicians can show their respect for them and 
clarify goals of care, expectations, needs and concerns (Lo, 2012, p.120). On the other 
hand, Lo warns unilateral decisions by physicians tend to polarize disagreements instead 
of resolving it. This is especially important considering that it has been empirically 
shown that many surrogates do not agree with physicians’ judgments of prognosis. A 
study done by Zier demonstrated that it is very common among surrogate decision 
makers to doubt about physicians’ ability to predict medical futility (Zier 2009). In this 
particular study, 64% of surrogates interviewed expressed doubts stemming from various 
reasons “including beliefs that individual physicians’ prediction may be unreliable, and 
need for surrogates to see for themselves the futility of a situation before accepting 
physicians’ prognostication, and the possibility that God will intercede to change patients’ 
outcomes” (Zier et al., 2009). Another study showed less than 2% of surrogates formed 
their beliefs about the patients’ prognosis based solely on prognostic information 
provided by physicians (Boyd et al., 2010). Boyd listed five other main factors that affect 
surrogates’ opinion about the patients’ prognosis:  “1) patient’s unique intrinsic qualities 
and will to live; 2) interpretations of the patient’s physical appearance or status; 3) the 
patient’s history of illness and / or survival; 4) surrogates’ beliefs in the power of their 
bedside presence; and 5) optimism, intuition, and faith” (Boyd et al., 2010). These 
findings demonstrate that the thought process of surrogates on patient’s prognostic 
estimates is vastly different from that of physicians. Thus physicians take this into 
consideration and communicate with surrogates accordingly.   
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 One approach for physicians to understand surrogate’s perspective and respond to 
their emotional needs is empathic comments. Lo argues:  
Empathic comments, which reflect the speaker’s emotions, encourage 
patients or surrogates to explore emotions and discuss difficult 
topics…Some physicians might fear that exploring emotions might 
arouse in the patient and family feelings of anger, hopelessness, or 
sadness that doctors are powerless to alleviate. Patients and families, 
however, will have these emotions whether or not physicians choose to 
probe them. After these emotions are discussed openly, the patients 
and family no longer must face them alone. Talking about emotional 
reactions to serious illness is frequently therapeutic and helps patients 
and families to accept a grave prognosis. Furthermore, anxiety and 
depression can be treated once they are identified. It is valuable for 
physicians to listen to patients and families. In turn, patients who feel 
they are understood might then be more willing to listen to the 
physician’s perspective (Lo, 2012, p.182). 
 
After physicians understand surrogates’ perspective and expectations, it is also important 
for them to address surrogates’ expectations when they are unrealistic. While physicians 
need to do so without destroying surrogates’ hope, it is also harmful to focus exclusively 
on hope. Back claims “exclusive focus on hope constricts options for discussing how a 
patient, family and physician can work together with a life threatening illness” (Back, 
Arnold, & Quill, 2003). Instead, by employing the dual approach, “Hope for the best, and 
prepare for the worst,” physicians can facilitate surrogates to address fears and clarify 
priorities without destroying their hope or limiting treatment options. This increases the 
chance to resolve potential issues of futility before it becomes inevitable. Another 
technique physicians can employ is “I wish statements.” Quill argues that while 
expressing empathy is critical, the means to do so is equally important. It has been 
observed that many physicians use the phrase “I am sorry” as their empathic response. 
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While this is well-intentioned and far from inappropriate, it can also be misinterpreted or 
misdirected. Instead, Quill found saying “I wish…(things were different)” to patient and 
surrogates is more a effective initial response (Quill, Arnold, & Platt, 2001). The 
advantage of this strategy is that an “I wish” statement can both acknowledge the hope 
and suggest the desired outcome is unrealistic. By allowing physicians to express both 
their empathy and limitation to families or surrogates, this technique will facilitate 
averting potential conflict between physicians and families over the issue of futility.  
 Lastly, Lo advises physicians to be sensitive to cultural and religious issues. For 
example, different cultures tend to have different perspectives on sufferings, death and 
pain. This is especially important at BMC where patients’ ethnic background is 
historically diverse. In addition, aforementioned articles stated surrogates’ religious 
beliefs have significant influence on how surrogates interpret the prognosis (Zier et al., 
2009; Boyd et al., 2010). 
 In sum, another systematic intervention BMC should consider is to improve 
education or training program on physicians’ communication skills with surrogates 
employing approaches or techniques listed above. In fact, the BMC medical intensive 
care unit has embarked on a quality improvement initiative to promote earlier 
communication between physicians and surrogates of critically ill patients about goals of 
care for patients with anticipated poor prognosis to try to prevent these types of ethical 
dilemmas from arising. 
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Critiquing the ACECS 
 
 As stated in the introduction section, there is yet to be an uniformly accepted  
standard documentation format of HCEC records. In addition, as described in earlier part 
the Comparing with the Past Studies section of the Discussion, different classification 
systems employed by different retrospective studies makes meaningful comparison 
among them extremely difficult. This signifies the importance of a standard coding 
system and the ACECS could well be one. As mentioned in the Methods section, the 
ACECS has significant advantages over other coding system, which include (but are not 
limited to) much broader subcategories. However, the ACECS is not without flaws. First, 
it only allows three codes (i.e. specific types of issues) to describe a consultation, while 
some of past studies never had such limits. When there are more than three codes that are 
appropriate, an evaluator needs to choose the three that best entails the core issue of the 
consultation. This is highly interpretive and thus subjectivity of the evaluator can play a 
larger role than other coding systems. In addition, by limiting the number of codes 
applied, the ACECS risks some types of issues needing attention to go unnoticed. In 
addition, while more codes for more specific types of issues makes evaluation more 
detailed, it forces an evaluator to explore more options during the coding process. Until 
the evaluator is fully trained and accustomed, it may force him to spend more time to 
code consultations than he would with less sophisticated coding system. In the field of 
medicine where physicians can spare only so much time, this issue is not negligible.  
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CONCLUSION 
 Using the ACECS, several common themes prompting ethics consultations at 
BMC were exposed. Specifically, the issue of futility / nonbeneficial treatment is 
arguably a type of issue that must be addressed first over others due to its implications 
and comparably higher frequency than those in past studies. This is a complex issue for 
which there’s not a silver bullet or quick fix, yet several interventions should be 
considered to address the issue at the systematic level.  
 There are some limitations with this particular study. First, it is easy to note that 
the sample size (32 consultations) is not very large. Second, as stated several times, 
comparison of results between this study and past studies are not necessarily perfect due 
to the different classification / coding systems they employed. Third, each consultation 
was coded by a person who has never been formally trained in the ACECS or as a M.D. 
While the coding was reviewed by a M.D. who is a member of the BMC and has been 
directly trained by Dr. Armstrong on the ACECS, there’s a chance that the coding would 
have been different if the sample was coded by a trained individual from the first place.  
 There are several things that can be done in the future studies. First, there should 
be a study with a larger sample size, which would not only give the identification of 
hotspots more validity but also would expose the characteristics of the ACECS (both pros 
and cons) more vividly. Another potential future study is more in-depth analysis 
regarding specific issues under substituted decision making. Unlike this study which used 
the ACECS, the vast majority of past studies never considered different specific types of 
issues regarding substituted decision making. As demonstrated by the examples in the 
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Introductions section, they usually had one big category “Substituted Decision Making,” 
which fails to describe the issue in more details. Using the ACECS, future studies will be 
able to decipher this particular subject group in more specific and detailed manner.   
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Recipient of Dean’s List, Fall 2008 
Relevant Course Work: Biochemistry, Introduction to Organic 
Chemistry,  
Cell Biology, Genetics, Behavioral Endocrinology, Complexity of 
Cancer, Introduction to Abnormal Psychology, Counseling 
Psychology, Lab Analysis of Psychological Data, Theory and 
Methods for Clinical Psychology, Introduction to Physiological 
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Psychology, Positive Psychology, Introduction to Bioethics, The 
Ethics and History of Human Experimentation, Medical Sociology 
    
 
Honors: 
2011 Spring  DIS Intercultural Leadership Award: Danish Institute for Study 
Abroad 
 
Research: 
2013 May – Present   Research to identify most prevalent types of ethical conflicts at 
Boston Medical Center using the Armstrong Clinical Ethics 
Coding System 
 Boston Medical Center, Boston, MA 
• Co-Researcher: Michael Ieong, MD,  Renda Wiener, MD, 
MPH 
• Supervisor: Michael Ieong, MD 
 
 
2009 Fall-2012 May   Research on predictors of readmission and future success rate of 
discharged somatoform disorder patients 
Johns Hopkins Hospital, Baltimore, MD 
• Co-Researcher: Amy Chang, Johns Hopkins University 
Undergraduate 
• Supervisor: Dr. Glenn Treisman, MD, PhD – Psychiatrist 
 
 
 
Extracurricular Activity: 
2011 Summer  Community Service at Project Place Baltimore, MD 
• Administrative work at the office 
 
2011 Spring Studying Abroad in Denmark with Danish Institution for Study 
Abroad (DIS) 
• Took classes such as Positive Psychology (core program), 
Complexity of Cancer, Introduction to Danish Language / 
Culture 
 
Herlev Rebels American Football Club in Herlev, Denmark 
• Played CB/WR/KR for 3 games, recorded 2 interceptions 
 
Community Service at Support and Contact Centre in Copenhagen, 
Denmark 
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• Volunteered in the Social Café at the Support and Contact 
Center, a mental health service offered by the Copenhagen 
City Counsel  
 
2009 Fall Medical Shadowing Experience at Johns Hopkins Hospital, 
Baltimore,    MD  
• Accompanied Dr. Glenn Treisman, MD, PhD – Psychiatrist, 
on clinical rounds 
 
2008-2012 May Japanese Student International (JSI) at Johns Hopkins University,    
    Baltimore, MD 
• Co-President in 2011, Organized Cultural Events and fund 
raisers  
 
 
